AAOM Webinar —
A Guide for Oral Mucosal Lesions: The Value of Risk Stratification
Join us on Zoom meetings for a webinar featuring speaker Dr. Anthony Morlandt and hosted by Dr. Jiwon Lim, Staff Clinician Dentist, NIDCR Dental Clinic
Sponsored by AAOM's 2024 Platinum Partner: Proteocyte
This webinar is good for CE credit: ADA CERP: 1 CE
Event Details
Wednesday, January 22, 2025
7:00 - 8:00 PM Eastern Time
Registration Fee
Complimentary — This webinar is being offered at no charge by AAOM.
Program Agenda / Webinar Description
Despite our best efforts as oral health specialists, management of Oral Potentially Malignant Disorders, (OPMD) has not changed substantively in nearly 50 years. Understanding future malignant potential of OPMD is critical, unfortunately, histopathology lacks prognostic or predictive potential, especially in the 70% of cases diagnosed as “mild” dysplasia or “no” dysplasia by WHO criteria. This webinar will discuss limitations in histopathology and opportunities using biomarker-based diagnostic adjuncts to improve management of OPMD, and, ultimately, oral squamous cell carcinoma.
Including both histopathologic and clinical items for consideration. Diagnostic adjuncts which are commercially available will be discussed.
Objectives
After reviewing this course work the participants should be able to:
- Understand accepted theories governing the pathophysiology of oral carcinogenesis and malignant transformation of OPMD lesions.
- Outline histopathology as a tool for predicting future malignant transformation of OPMD lesions into oral squamous cell carcnoma.
- Discuss biomarker-based adjuncts to diagnose and manage OPMD based on risk of future malignant potential, as opposed to clinicopathologic risk factors alone.
Meet the Speaker
|
Dr. Anthony Morlandt, MD, DDS, FACS
Chief of the Section of Oral Oncology, Department of Oral and Maxillofacial Surgery
University of Alabama at Birmingham (UAB)
Dr. Morlandt is the Waite Endowed Professor, Vice Chair, and Chief of the Section of Oral Oncology, Department of Oral and Maxillofacial Surgery at the University of Alabama at Birmingham (UAB) Medicine and is an academic head and neck surgeon. He directs the Oral/Head and Neck Oncology Fellowship Program at UAB and is a Scientist in the Cancer Chemoprevention Program with the UAB O’Neal Comprehensive Cancer Center. His primary academic mission is to improve detection and survival for patients suffering from pre-invasive or invasive head and neck tumors.
|
|
